REWIRE - Rehabilitative Wayout In Responsive Home Environments, A Pilot Trial

NCT02192125 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2015-09-15

No results posted yet for this study

Summary

The study examines the possible application of the rehabilitation platform REWIRE.

Conditions

Interventions

DEVICE

REWIRE-System

The REWIRE rehabilitation platform consists of three hierarchical components: 1. "patient station" (PS), which is installed in the home environment of the patient: Includes: Laptop with software - Game Tymoplate® - balanceboard Kinect® - 3D tracking 2. "Hospital Station" (HS), which allows an exchange of information with more "patient station" and is served by the therapists in the hospital; Includes: Laptop MySQL- database 3. "station networking" (NS), which allows a combination of a several of HS. database

Sponsors & Collaborators

  • University of Milan

    collaborator OTHER
  • Ecole Polytechnique Fédérale de Lausanne

    collaborator OTHER
  • University of Oxford

    collaborator OTHER
  • University of Padova

    collaborator OTHER
  • Swiss Federal Institute of Technology

    collaborator OTHER
  • Ab.Acus Srl

    collaborator INDUSTRY
  • Fundación Pública Andaluza Progreso y Salud

    collaborator OTHER
  • Technogym SpA

    collaborator UNKNOWN
  • Fundació Privada Barcelona Digital Centre Tecnològic (BDIGITAL)

    collaborator UNKNOWN
  • University Hospital, Zürich

    collaborator OTHER
  • JSI Research & Training Institute, Inc.

    collaborator OTHER
  • Hospitales Universitarios Virgen del Rocío

    collaborator OTHER
  • University of Zurich

    lead OTHER

Principal Investigators

  • Andrea R Luft, Prof. · University of Zurich

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02192125 on ClinicalTrials.gov